Gestalt wrote, We are way overdue for the NASH res
Post# of 148152
Quote:
We are way overdue for the NASH results and we still are not sure if Cancer patients are still getting Lerolimab.
We should get answers to both of those questions this month. The results of the three pooled mTNBC trials are being presented to the ASCO conference in a few days, and then the NASH results are to posted at the International Liver Conference in London from the 22nd to the 26th.